Jennifer Burstein, Senior VP of Finance at Loxo Oncology, Inc. (LOXO), sold 2,500 shares at $130.79 ($339K) on 2018-12-10, disclosed to the SEC on 2018-12-12.
Open-market sale of $339k LOXO by Senior VP of Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.79 | 100 | $13K | 3.9% |
| 2 | $132.44 | 400 | $53K | 15.6% |
| 3 | $133.34 | 100 | $13K | 3.9% |
| 4 | $134.71 | 550 | $74K | 21.9% |
| 5 | $136.04 | 100 | $14K | 4.0% |
| 6 | $135.69 | 200 |
| $27K |
| 8.0% |
| 7 | $136.98 | 587 | $80K | 23.7% |
| 8 | $137.88 | 263 | $36K | 10.7% |
| 9 | $139.36 | 100 | $14K | 4.1% |
| 10 | $140.48 | 100 | $14K | 4.1% |
| Total | $135.55 avg | 2,500 | $339K | 100% |
| Filing → |
| LOXO | SELL | 2018-09-14 | $667K | — | Filing → |
| LOXO | SELL | 2018-08-15 | $540K | — | Filing → |
| LOXO | SELL | 2018-07-11 | $281K | — | Filing → |